Table 3.

Mean years to SCC progression, sensitivity, specificity, accuracy, OR, and median immunostain score for precancerous lesions and SCC

Mean years to SCC (SD)Sensitivity (%)Specificity (%)Accuracy (%)OR (95% CI)Mean score (SD)
No histologic atypia3.0 (2.8)71.974.273.48.6 (3.7-19.8)0.39 (0.36)
Atypia/dysplasia2.9 (2.7)82.174.276.514.3 (4.9-41.5)0.55 (0.45)
Precancerous lesion (combined above two rows)2.976.074.275.110.5 (4.8-22.6)
SCC91.774.280.029.8 (9.4-94.6)0.54 (0.40)
Precancerous lesions progressing to SCC
    In <3 y64.374.271.25.8 (2.4-13.8)
    After >3 y85.274.278.219.9 (7.3-55.5)